Back to stocks
RNA

RNA

Atrium Therapeutics, Inc.• Healthcare

Q3 2026 filings are still coming in. 13F filers have 45 days after the quarter ends to report, through November 14, 2026. These totals cover only the funds that have filed so far and will keep rising.
Institutional holders
18
Partial Q3 2026
Total 13F value
$735K
Filed positions so far
New positions
3
This quarter
Sold positions
8
This quarter

Top holders

Institutions with disclosed positions in this stock

FundValueShares% PortfolioChange

Trium Capital Llp

$483K58.4K0.61%-48.5%

Kestra Private Wealth Services, Llc

$100K12.1K0.00%+16.5%

Wealth Enhancement Advisory Services, Llc

$97K11.7K0.00%New Position

Strs Ohio

$31K3.7K0.00%+42.3%

Versant Capital Management, Inc

$8K9310.00%+251.3%

Covestor Ltd

$4K4680.00%+0.4%

Sterling Capital Management Llc

$3K4150.00%+232.0%

Gamma Investing Llc

$3K3690.00%+89.2%

Fny Investment Advisers, Llc

$2K3300.00%+26.9%

Pinnacle Wealth Planning Services, Inc.

$9521150.00%+1050.0%

Essential Partners Llc

$654790.00%-72.6%

Nisa Investment Advisors, Llc

$636770.00%Unchanged

Sjs Investment Consulting Inc.

$605730.00%+711.1%

Parkside Financial Bank & Trust

$497600.00%New Position

True Wealth Design, Llc

$340410.00%-80.8%

Fortitude Family Office, Llc

$182220.00%-56.0%

Farther Finance Advisors, Llc

$149180.00%-85.0%

Root Financial Partners, Llc

$2530.00%New Position

Explore